{"id":3848,"date":"2023-08-29T11:55:28","date_gmt":"2023-08-29T16:55:28","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&p=3848"},"modified":"2025-06-18T17:35:42","modified_gmt":"2025-06-18T22:35:42","slug":"recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicacoes\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/","title":{"rendered":"Recomendaciones para implementar “Reliance” regulatorio para la evaluaci\u00f3n de cambios post-registro"},"content":{"rendered":"\n

Los cambios post-registros de medicamentos han aumentado r\u00e1pidamente en los \u00faltimos a\u00f1os, y a un ritmo m\u00e1s r\u00e1pido de lo que las Autoridades Reguladoras Nacionales (ARNs) pueden manejar de manera confiable. Esto es tanto una preocupaci\u00f3n como un desaf\u00edo para los pa\u00edses de Am\u00e9rica Latina. La Organizaci\u00f3n Mundial de la Salud (OMS) ha publicado recientemente dos documentos que ser\u00e1n fundamentales para las actividades de fortalecimiento del sistema regulatorio de los pa\u00edses, incluida la cooperaci\u00f3n, convergencia y transparencia regulatoria.<\/p>\n\n\n\n

Visualizar<\/a><\/div>\n\n
\n\n\t\t\n
    \n\t\t\t <\/ul>\n <\/div> \n","protected":false},"author":24,"parent":0,"template":"","ano":[53],"idioma":[31],"etiquetas-publicacion":[148],"categoria-publicacion":[29],"class_list":["post-3848","publicaciones","type-publicaciones","status-publish","hentry","ano-53","idioma-espanol","etiquetas-publicacion-reliance","categoria-publicacion-reporte"],"yoast_head":"\nRecomendaciones para implementar "Reliance" regulatorio para la evaluaci\u00f3n de cambios post-registro - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recomendaciones para implementar "Reliance" regulatorio para la evaluaci\u00f3n de cambios post-registro\" \/>\n<meta property=\"og:description\" content=\"Los cambios post-registros de medicamentos han aumentado r\u00e1pidamente en los \u00faltimos a\u00f1os, y a un ritmo m\u00e1s r\u00e1pido de lo que las Autoridades Reguladoras Nacionales (ARNs) pueden manejar de manera confiable. Esto es tanto una preocupaci\u00f3n como un desaf\u00edo para los pa\u00edses de Am\u00e9rica Latina. La Organizaci\u00f3n Mundial de la Salud (OMS) ha publicado recientemente […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T22:35:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\\\/\",\"name\":\"Recomendaciones para implementar \\\"Reliance\\\" regulatorio para la evaluaci\u00f3n de cambios post-registro - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2023-08-29T16:55:28+00:00\",\"dateModified\":\"2025-06-18T22:35:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Recomendaciones para implementar “Reliance” regulatorio para la evaluaci\u00f3n de cambios post-registro\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Recomendaciones para implementar \"Reliance\" regulatorio para la evaluaci\u00f3n de cambios post-registro - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/","og_locale":"pt_BR","og_type":"article","og_title":"Recomendaciones para implementar \"Reliance\" regulatorio para la evaluaci\u00f3n de cambios post-registro","og_description":"Los cambios post-registros de medicamentos han aumentado r\u00e1pidamente en los \u00faltimos a\u00f1os, y a un ritmo m\u00e1s r\u00e1pido de lo que las Autoridades Reguladoras Nacionales (ARNs) pueden manejar de manera confiable. Esto es tanto una preocupaci\u00f3n como un desaf\u00edo para los pa\u00edses de Am\u00e9rica Latina. La Organizaci\u00f3n Mundial de la Salud (OMS) ha publicado recientemente […]","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-18T22:35:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/","url":"https:\/\/fifarma.org\/publicaciones\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/","name":"Recomendaciones para implementar \"Reliance\" regulatorio para la evaluaci\u00f3n de cambios post-registro - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2023-08-29T16:55:28+00:00","dateModified":"2025-06-18T22:35:42+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/recomendaciones-para-implementar-reliance-regulatorio-para-la-evaluacion-de-cambios-post-registro\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Recomendaciones para implementar “Reliance” regulatorio para la evaluaci\u00f3n de cambios post-registro"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/3848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=3848"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=3848"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=3848"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=3848"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=3848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}